Skip to main content

Decitabine

NDC 55111-556 · Dr.Reddy's Laboratories Limited

Generic nameDecitabine
Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
RouteINTRAVENOUS
Active ingredient(s)DECITABINE
Strength50 mg/10mL
Pharmacologic classNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
Marketing categoryANDA

Packages

55111-556-10 — 1 VIAL, SINGLE-USE in 1 CARTON (55111-556-10) / 10 mL in 1 VIAL, SINGLE-USE

Billed under HCPCS

J0894 — Injection, decitabine, 1 mg Medicare Part B payment limit (ASP + 6%): $1.10

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0143-9385 — decitabine, 16729-224 — decitabine, 25021-219 — Decitabine, 31722-304 — Decitabine, 43598-427 — Decitabine, 55150-376 — Decitabine, 64842-0727 — CEDAZURIDINE and DECITABINE, 67184-0535 — decitabine, 67457-316 — decitabine, 68001-573 — decitabine, 68001-618 — Decitabine, 68001-642 — Decitabine, 68083-528 — decitabine, 70121-1644 — decitabine, 71288-119 — Decitabine, 72162-2634 — Decitabine, 72205-031 — Decitabine, 72205-036 — Decitabine, 72603-107 — Decitabine, 75834-190 — decitabine

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources